These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9648457)

  • 1. [Recent advances in biology of bone resorption].
    Inoue D; Matsumoto T
    Nihon Rinsho; 1998 Jun; 56(6):1412-8. PubMed ID: 9648457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commitment and differentiation of stem cells to the osteoclast lineage.
    Hayashi S; Yamane T; Miyamoto A; Hemmi H; Tagaya H; Tanio Y; Kanda H; Yamazaki H; Kunisada T
    Biochem Cell Biol; 1998; 76(6):911-22. PubMed ID: 10392705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoclasts in bone metabolism].
    Hakeda Y; Kumegawa M
    Kaibogaku Zasshi; 1991 Aug; 66(4):215-25. PubMed ID: 1759556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.
    Fuller K; Owens JM; Chambers TJ
    J Immunol; 1995 Jun; 154(11):6065-72. PubMed ID: 7751648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
    Vanhara P; Smarda J
    Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines and osteoclastic action].
    Chenu C
    Pathol Biol (Paris); 1989 Jun; 37(6):768-75. PubMed ID: 2674878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bone loss.
    Murray TM
    J Rheumatol Suppl; 1996 Aug; 45():6-10. PubMed ID: 8856644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and growth factors in the regulation of bone remodeling.
    Mundy GR
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S505-10. PubMed ID: 7510095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption.
    Granot-Attas S; Elson A
    Eur J Cell Biol; 2008 Sep; 87(8-9):479-90. PubMed ID: 18342392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics.
    Zaidi M; Blair HC; Moonga BS; Abe E; Huang CL
    J Bone Miner Res; 2003 Apr; 18(4):599-609. PubMed ID: 12674320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in bone biology: the osteoclast.
    Roodman GD
    Endocr Rev; 1996 Aug; 17(4):308-32. PubMed ID: 8854048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of beta 3 subunit of integrins in osteoclast membrane.
    Teti A; Grano M; Carano A; Colucci S; Zambonin Zallone A
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1031-7. PubMed ID: 2629822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.
    Gupta N; Barhanpurkar AP; Tomar GB; Srivastava RK; Kour S; Pote ST; Mishra GC; Wani MR
    J Immunol; 2010 Aug; 185(4):2261-72. PubMed ID: 20644169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.